Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study

According to the Center for Disease Control and Prevention, as of August 23, 94 countries had confirmed 42,954 Monkeypox Virus cases. As specific monkeypox drugs are not yet developed, the treatment depends on repurposed FDA-approved drugs. According to a recent study, the Monkeypox outbreak is caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Varshita, Naik, Biswajit, Godara, Priya, Das, Dorothy, Mattaparthi, Venkata Satish Kumar, Prusty, Dhaneswar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116100/
https://www.ncbi.nlm.nih.gov/pubmed/37079243
http://dx.doi.org/10.1007/s11030-023-10636-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116100/
https://www.ncbi.nlm.nih.gov/pubmed/37079243
http://dx.doi.org/10.1007/s11030-023-10636-4

Ejemplares similares